NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
MASSACRE OF HEALTHCARE PROVIDERS OF COLOR
In 2009, United States President Barack Obama was awarded the Nobel Peace Prize for his exceptional endeavors to strengthen international diplomacy and foster cooperation among people.
A decade later, the echoes of his legacy resonate as a beacon of hope for unity and progress. However, amidst the strides towards harmony, there looms a stark reminder of America’s tumultuous past—the Tulsa race massacre.
The Tulsa race massacre, often referred to as the Tulsa race riot or the Black Wall Street massacre, remains a haunting testament to the depths of racial hatred and violence in American history.
In May 1921, the Greenwood District in Tulsa, Oklahoma, a thriving black community known as “Black Wall Street,” was ravaged by white supremacist mobs.
Over the course of two harrowing days, homes and businesses were razed, lives were lost, and a legacy of trauma was acid etched into the fabric of the nation.
“I’M A DOCTOR NOT A DRUG DEALER”
Today, as we confront the challenges of our time, another form of devastation threatens to engulf our society—the erosion of trust and integrity in the field of medicine. This insidious process, which I call the “Tulsafication” of medicine, is fueled by policies and attitudes that undermine the fundamental principles of healthcare and perpetuate disparities in access and quality of care.
At the forefront of this assault on healthcare was Attorney General Jeffery Sessions, whose regressive policies pose a grave threat to the well-being of millions of Americans. Sessions’ relentless efforts to dismantle crucial healthcare protections, such as the Affordable Care Act, and his draconian approach to drug policy have sown seeds of discord and disillusionment within the medical community.
I’ve Served My Country “I am a physician not a drug dealer”
I served this Country as a Naval Medical Officer during a time of War, I was in New York September 11, 2001.
I saw the explosion when the planes hit both Twin Towers and I went to worked saving lives I was a youngest physician at the Trade Center site and it was this attack on our Country that inspired me to sign-up for the U.S. Navy.
A JUDICIAL SMASH AND GRAB OPERATION CAUSED BY FAILURE OF CONGRESSIONAL OVERSIGHT
“I AM A DOCTOR NOT A DRUG DEALER“
Dr. L. Joseph Parker, MD is a distinguished professional he is a rare blend of scientific expertise, military leadership, and medical acumen to contribute significantly to the advancement of science and the betterment of human health and safety.
He writes as an advocate for physicians and patients and for the humane treatment of those suffering from addiction and the incarcerated.
Dr. Parker pursued studies at Mayo Medical School and joined the U.S. Medical Corps, ultimately achieving the rank of Captain. Having personally suffered wrongful convictions as a drug dealer in a “White Coat,” gives him a unique perspective on the American justice and prison system, and he has dedicated himself to advocacy for the wrongfully prosecuted.
these d.e.a. raids are looting operation of our ANCESTRAL propertIES
Physicians, Pharmacists, Dentists, et al., and our patients, families are victimized because of D.E.A ‘s failures, corruption and deviant sexual indiscretions with prostitutes, provided to them, along bribes by the Cartel’s in both Afghanistan and South/ Central America thus compromising our Nation Security.
We are not a Drug Dealer. Like many of my colleagues in medicine we have become easy pickens, the Alfred Dreyfus’s of the D.E.A and DOJ prosecutors; easy enforcement targets because of our assets and we are mostly unarmed and don’t shoot back.
The Dreyfus affaire is an good historical parallel to the due process crimes now being committed by DEA and DOJ
Dr. David Stein, MD writes;
“The Dreyfus affaire in 19th century France involved the creation of fake documents against Captain Dreyfus that purported to show that the officer was sending secret military intelligence to the Germans.
Dreyfus was Jewish and an easy scapegoat. In the beginning, the media was eager to parrot the government line. Dreyfus was charged with treason, got a sham trial and sent off to the infamous penal colony of Devils Island off the coast of South America.
What has happened was that the government based prosecution on a false narrative. It was based on contrived algorithms that were in turn based on junk science.
Now it’s clear to anyone that would look into the matter that their “evidence” that prescription opioids caused the increased opioid deaths is fraudulent.
Alfred Dreyfus, languished there for years but the truth came out and the person responsible for the fraudulent evidence was discovered.
At least the French Judicial System eventually acknowledged and admitted their errors.”
” It’s now a wonder if whether the U.S. so called “Justice” System will have the integrity to admit their mistakes? ”
“WE strongly doubt it though”
“…And Carl Nelson, This Ain’t News???…”
TULSAFICATION OF OUR HEALTHCARE AND THE AFORDABLE HEALTHCARE ACT
In the face of such adversity, there is a dire need for leadership that embodies the spirit of compassion, equity, and justice. President Obama, with his unwavering commitment to progress and inclusivity, stands as a beacon of hope in these troubled times. As the architect of landmark healthcare reforms and a champion of social justice, he possesses the moral authority and the political acumen to confront the forces of division and restore integrity to medicine.
According to Ms. Szalavitz is a contributing Opinion writer who covers addiction and public policy.
“There are countless other accounts like these. Five million to eight million Americans currently rely on opioids to treat chronic pain, and thousands need them for end-of-life pain at any given time.
Despite their risks, opioids remain the best available pain treatment for many patients — and there is little evidence that addictions are prevented or treated by denying them to those who have already used them safely for years. Concerns about the harms associated with indiscriminate cutbacks have been raised by the Centers for Disease Control and Prevention, the Food and Drug Administrationand major medical organizations.
“We are not finished, We are not giving up”
Nevertheless, doctors continue to abandon these patients while the overdose crisis worsens. Since 2012, the dosage strength of opioid prescriptions decreased by 60 percent, and the number of prescriptions has fallen by nearly half. During that time, the age-adjusted rate of opioid overdose deaths in the population has more than tripled.
And now the Drug Enforcement Administration wants a further 8 percent cut in manufacturing quotas for some opioids in 2024, even though shortages detrimental to treatment are already being reported by physicians.”
The dilemma
Excerpts from March 22, 2024 article in New York Times Opinion: D.E.A. NEEDS TO STAY OUT OF MEDICINE
“I’m still haunted by the fact that my husband and I, both anesthesiologists and pain physicians who have made it our life’s work to alleviate the suffering of those in pain, could not help her.
It is no wonder that our patients are frustrated. They do not understand why we, doctors whom they trust, send them on wild goose chases.
They do not understand how pharmacies fail to provide the medications they need to function. They do not understand why the system makes them feel like “drug seekers.” Health care professionals and pharmacies in this country are chained by the Drug Enforcement Administration.”
“..we must be like John..”
pain care and reproductive healthcare are one in the same
Our patients’ stress is not the result of an orchestrated set of practice guidelines or a comprehensive clinical policy but rather one government agency’s crude, broad-stroke technique to mitigate a public health crisis through manufacturing limits — the gradual and repeated rationing of how much opioids can be produced by legitimate entities.
This is a bad and ineffective strategy to solving the opioid crisis, and it’s incumbent on us to hand the reins of authority over to public health institutions.
THIS PRIZE USED TO GIVE MOMENTUM TO A SET OF CAUSES
President Obama must heed the call to action and mobilize a coalition of healthcare professionals, policymakers, and advocates to resist the onslaught of policies that threaten to exacerbate disparities in healthcare access and undermine the sanctity of the doctor-patient relationship.
By leveraging his influence and moral authority, he can galvanize public support for initiatives that promote health equity, expand access to affordable care, and combat systemic injustices within the healthcare system.
Moreover, President Obama must confront the legacy of the Tulsa race massacre and its enduring impact on the health and well-being of black communities across America. Just as the Greenwood District rose from the ashes of destruction, so too must we strive to build a healthcare system that upholds the dignity and humanity of all individuals, regardless of race, ethnicity, or socioeconomic status.
In the face of adversity, we must draw strength from the lessons of our past and the vision of a more just and equitable future. President Obama has the opportunity to lead the charge in this pivotal moment, to chart a course towards a healthcare system that reflects the values of compassion, equity, and solidarity.
Together, we can overcome the forces of division and injustice and forge a path towards healing and reconciliation. The time to act is now, and President Obama must rise to the challenge and halt the “Tulsafication” of medicine before it’s too late.
OR SEND
TO CASH APP:$docnorm
ZELLE 3135103378
So, Donate to the “Pharmacist For Healthcare Legal Defense Fund,
FOR NOW, YOU ARE WITHIN
THE NORMS
REFERENCES:
ORDERS TO SHOW CAUSE
IN THE MATTER OF PRONTO PHAARMACY LLC
From: “Dale R. Sisco” <dsisco@sisco-law.com>
Subject: Compounding regulations
Date: May 2, 2017 at 2:30:24 PM EDT
To: “prontopharmacy@aol.com” <prontopharmacy@aol.com>, “normanclement@me.com” <normanclement@me.com>
Norman – I have reviewed the new DOH complaint. One of the individuals present, Amie Hickerson, is the new Diversion Group Supervisor in the Tampa DEA Office. She replaced Roberta Goralczyk. Her participation in this inspection is particularly troubling because the DEA is cracking down on compounding pharmacies. Two important aspects of the distinction between “dispensing” and “manufacturing” are that retail pharmacies are permitted to (1) compound only for a specific patient; and (2) cannot compound drugs that are otherwise commercially available. I have attached the Food Drug & Cosmetic Act to this email. While it may allow a licensed pharmacist to compound “limited quantities” before the receipt of an actual prescription, such “limited quantities” must be based upon a history of valid prescription orders for compounded product for a specific patient.
I need to see some of the prescriptions and need to know the identity of the prescriber authorizing the compounding. Also, you cannot permit the patient to determine if the compounded drug is in capsule or tablet form.
Drug compounding is a process by which a pharmacist or doctor combines, mixes, or alters ingredients to create a medication tailored to the needs of an individual patient. Compounding is typically used to prepare medications that are not commercially available, such as medication for a patient who is allergic to an ingredient in a mass produced product.
The CSA clearly permits pharmacies to compound controlled substances as part of the act of dispensing, and exempts such compounding from the definition of manufacture. The FD&C similarly exempts pharmacies that compound as part of retail pharmacy practice from the manufacturing requirements of that statute. However, in recent years some pharmacies have increased their compounding activities to such an extent that the Food and Drug Administration (FDA) became concerned that some pharmacies are using compounding as a guise to manufacture drugs.
In response to that concern, in 1997 Congress passed the Food and Drug Administration Modernization Act of 1997, Pub. L. 105-115. Included in the statute at Section 127 was a provision which amended the FD&C at 21 U.S.C. 353a. This provision was entitled “Application of Federal Law to the Practice of Pharmacy Compounding,” which exempted pharmacies from drug approval provisions of the FD&C relating to manufacturing when they compounded drugs under certain circumstances. The legislative history of this provision found in the House Conference Report states that “[i]t is the intent of the conferees to ensure continued availability of compounded drug products as a component of individualized therapy, while limiting the scope of compounding so as to prevent manufacturing under the guise of compounding.” 1997 U.S.C.C.A.N. 2880.
Against this backdrop, to be exempt from the definition of manufacturer under the CSA a DEA practitioner registrant must be engaged in compounding controlled substances on an individual patient basis. That is, a pharmacy must receive a prescription for a specific patient from a physician or other individual practitioner and must deliver or dispense that medication to the patient.
IN THE MATTER OF AARIC,INC d/b/a AT COST RX
IN THE MATTER OF GULF MED PHARMACY, NAPLES FLORIDA
IN THE MATTER OF OAK HILL PHARMACY
“I AM A PHYSICIAN NOT A DRUG DEALER”
IN THE MANNER OF DR. Neil Anand, MD
IN THE MANNER OF DR. LEWIS LADSON, RPH D.B.A LINCOURT PHARMACY
- Title
Diversion Program Manager
Dates Employed
Aug 2020 – Present
Employment Duration
1 yr
Location
Atlanta, Georgia, United States
Diversion Program Manager for the Atlanta Division over the Diversion Program in Carolinas and Georgia.
Title
Diversion Training Unit Chief
Dates Employed
Jun 2019 – Aug 2020
Employment Duration
1 yr 3 mos
Location
Quantico, Virginia, United States
Title
Group Supervisor
Dates Employed
Aug 2016 – Jun 2019
Employment Duration
2 yrs 11 mos
Location
Tampa, Florida, United States
Title
Diversion Investigator
Dates Employed
Apr 2004 – Aug 2016
Employment Duration
12 yrs 5 mos
Location
Columbia, South Carolina, United States- Drug Enforcement Administration
Thanks for exposing real cause of drug related deaths in AMERICA due to illegal synthetic and opioid laced drugs and not doctor administered safe meds to alleviate pain of legitimate patients.